Balaxi Pharmaceuticals Limited (NSE:BALAXI)
India · Delayed Price · Currency is INR 23.67
-0.46 (-1.91%)
Jul 3, 2026, 3:29 PM IST
Balaxi Pharmaceuticals Market Cap
Balaxi Pharmaceuticals has a market cap or net worth of 1.31 billion as of July 2, 2026. Its market cap has decreased by -51.50% in one year.
Market Cap
1.31B
Enterprise Value
1.74B
Revenue
2.70B
Ranking
n/a
PE Ratio
91.04
Stock Price
23.67
Market Cap Chart
Since December 1, 2015, Balaxi Pharmaceuticals's market cap has increased from 41.50M to 1.31B, an increase of 3,049.13%. That is a compound annual growth rate of 38.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 1.31B | -11.91% |
| Dec 31, 2025 | 1.48B | -59.70% |
| Dec 31, 2024 | 3.68B | -16.38% |
| Dec 29, 2023 | 4.40B | -27.68% |
| Dec 30, 2022 | 6.09B | 18.63% |
| Dec 31, 2021 | 5.13B | -21.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 15.78B |
| Sigachi Industries | 8.75B |
| Bafna Pharmaceuticals | 5.22B |
| Valiant Laboratories | 3.52B |
| Nectar Lifesciences | 2.31B |
| Brooks Laboratories | 2.24B |
| Alpa Laboratories | 1.45B |
| Par Drugs and Chemicals | 1.09B |